Drug safety :
hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Eighty-eighth Congress, second session.
Description
- Language(s)
-
English
- Published
-
Washington : U.S. G.P.O., 1964-
- Summary
-
Pt. 5--Continuation of hearings on FDA drug safety regulations and requirements. Focuses on approval of DMSO (dimethyl sulfoxide).
Pt. 4--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA role in monitoring pharmaceutical companies manufacturing practices. Focuses in part on case involving mixup of labels on a number of drugs produced by Abbott Laboratories of North Chicago, Ill.
Pt. 3--Continuation of hearing on controls over drugs that may be released for public consumption. Examines FDA organization, policies and procedures for processing applications for testing investigational drugs. Focuses in part on the anti-depressant drug Parnate that was approved for sale but taken off the market.
Pt. 2--Surveys VA and NIH drug safety research programs, and investigates FDA drug approval process for Flexin and Orabilex.
Pt. 1--Surveys FDA, AMA, and pharmaceutical industry drug safety research and regulatory programs.
Hearings held Mar. 9, 10, May 25, 26, June 7-9, 1966--pt. 5.
Hearings held July 20, 22, 27, Aug. 3, 10, Sept. 24, 1965--pt. 4.
- Note
-
Hearings held before the Eighty-eighth Congress, second session and other sessions of later Congresses.
"Intergovernmental Relations Subcommittee'--Pt. 1, page 1.
- Physical Description
-
5 volumes :
illustrations ;
23 cm
Viewability